What Is Fenoterol?
Fenoterol hydrobromide, also known as phenprothin, isoproterenol, is a highly effective bronchodilator for the treatment of bronchial asthma and other reversible airway strictures such as chronic obstructive bronchitis Or accompanied by emphysema. This medicine can also be used to prevent bronchospasm caused by exercise. Its active ingredient, fenoterol hydrobromide, can promote airway clearance mechanism. Acute asthma attacks to prevent exercise-induced asthma. Also used for allergic rhinitis.
Fenoterol hydrobromide
- Chinese name
- Fenoterol hydrobromide
- Foreign name
- Fenoterol Hydrobromide
- Alias
- Phenprothin, isoproterenol
- aerosol
- 20ml: 100mg;
- Effect
- Preventing bronchospasm caused by exercise
- Fenoterol hydrobromide, also known as phenprothin, isoproterenol, is a highly effective bronchodilator for the treatment of bronchial asthma and other reversible airway strictures such as chronic obstructive bronchitis Or accompanied by emphysema. This medicine can also be used to prevent bronchospasm caused by exercise. Its active ingredient, fenoterol hydrobromide, can promote airway clearance mechanism. Acute asthma attacks to prevent exercise-induced asthma. Also used for allergic rhinitis.
- This medicine is a highly effective bronchodilator for the treatment of bronchial asthma and other reversible airway stenoses such as chronic obstructive bronchitis or emphysema. This medicine can also be used to prevent bronchospasm caused by exercise. Its active ingredient, fenoterol hydrobromide, can promote airway clearance mechanism. Acute asthma attacks to prevent exercise-induced asthma. Also used for allergic rhinitis.
- Aerosol inhalation: 0.1ml (2 drops) / time for adults, 0.05ml / time for children, 3 to 4 times / day. Oral: 2.5mg ~ 7.5mg / time, 3 times / day, children should be reduced.
- Use with caution in patients with hyperthyroidism, cardiac insufficiency, angina pectoris, arrhythmia, and hypertension. Uncontrolled diabetes, recent myocardial infarction or severe organic cardiovascular disease, patients with hyperthyroidism should be used with caution, and acute and rapid progressive dyspnea must be treated first aid. In the process of controlling airway inflammation, it should be considered whether it is necessary to combine and increase anti-inflammatory drugs (such as inhaled corticosteroids) to control airway inflammation and prevent long-term airway injury. Long-term high-dose use of b2 receptor agonists to control the symptoms of airway obstruction may cause a decrease in disease control ability. Treatment with b2 receptor agonists may lead to hypokalemia, especially in severe asthma, such as combined use of xanthine derivatives, hormones and diuretics should pay special attention. In addition, hypoxia can worsen the effects of hypokalemia on heart rhythm. Impact on pregnancy and lactation: Based on past experience, there is no adverse effect when used during pregnancy. However, caution must be taken during pregnancy (especially the first 3 months). This drug has an inhibitory effect on uterine contraction, and the safety of the drug during breastfeeding has not been fully determined.